Ferrer-Lopez P - Search Results

1

[Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK].

Messekher M, François H, Denis MG, Ferrer-Lopez P, Bost-Bezeaud F, Mazières J, Parrat E. Messekher M, et al. Among authors: ferrer lopez p. Rev Mal Respir. 2024 May 24:S0761-8425(24)00211-0. doi: 10.1016/j.rmr.2024.05.003. Online ahead of print. Rev Mal Respir. 2024. PMID: 38796386 French.

2

Molecular profiling of patients with advanced lung adenocarcinoma diagnosed between 2015 and 2020 in French Polynesia.

Messekher M, François H, Denis MG, Ferrer-Lopez P, Bost-Bezaud F, Mazières J, Parrat É. Messekher M, et al. Among authors: ferrer lopez p. Respir Med Res. 2023 Nov;84:101059. doi: 10.1016/j.resmer.2023.101059. Epub 2023 Nov 11. Respir Med Res. 2023. PMID: 38035867 No abstract available.

3

[One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].

Grivaux M, Duvert B, Ferrer-Lopez P, Hominal S, Goarant E, Brichet-Martin A, Romand P, Fournier E, Asselain B, Debieuvre D. Grivaux M, et al. Among authors: ferrer lopez p. Rev Pneumol Clin. 2016 May;72(3):163-70. doi: 10.1016/j.pneumo.2016.02.002. Epub 2016 Apr 22. Rev Pneumol Clin. 2016. PMID: 27113617 French.

4

[Characteristics and management of acute exacerbations of COPD in hospital. EABPCO-CPHG study by the college of general hospital respiratory physicians].

Piquet J, Chavaillon JM, David P, Martin F, Braun D, Ferrer Lopez P, Chemery L, Bénichou-Flurin M, Goupil F, Le Poulain-Doubliez M, Arvin-Berod C, Moncelly L, Lebas FX, Maurer C, Dujon C, Mornet M, Roche N, Zureik M, Blanchon F. Piquet J, et al. Among authors: ferrer lopez p. Rev Mal Respir. 2010;27(1):19-29. doi: 10.1016/j.rmr.2009.11.007. Epub 2009 Dec 16. Rev Mal Respir. 2010. PMID: 20146948 French.

5

[The risk from inhaled glucocorticoids in childhood asthma].

Ferrer López P. Ferrer López P. Arch Bronconeumol. 1995 Aug-Sep;31(7):371. Arch Bronconeumol. 1995. PMID: 8777535 Spanish. No abstract available.

6

Heparin inhibits neutrophil-induced platelet activation via cathepsin G.

Ferrer-Lopez P, Renesto P, Prevost MC, Gounon P, Chignard M. Ferrer-Lopez P, et al. J Lab Clin Med. 1992 Mar;119(3):231-9. J Lab Clin Med. 1992. PMID: 1541873

7

Eglin C and heparin inhibition of platelet activation induced by cathepsin G or human neutrophils.

Renesto P, Ferrer-Lopez P, Chignard M. Renesto P, et al. Among authors: ferrer lopez p. Ann N Y Acad Sci. 1991;624:321-4. doi: 10.1111/j.1749-6632.1991.tb17033.x. Ann N Y Acad Sci. 1991. PMID: 2064235 No abstract available.

8

Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.

Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M. Ferrer-Lopez P, et al. Am J Physiol. 1990 Jun;258(6 Pt 1):C1100-7. doi: 10.1152/ajpcell.1990.258.6.C1100. Am J Physiol. 1990. PMID: 2360620

9

Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.

Renesto P, Ferrer-Lopez P, Chignard M. Renesto P, et al. Among authors: ferrer lopez p. Lab Invest. 1990 Apr;62(4):409-16. Lab Invest. 1990. PMID: 2159081

10

From anti-asthma drugs to PAF-acether antagonism and back. Present status.

Pretolani M, Ferrer-Lopez P, Vargaftig BB. Pretolani M, et al. Among authors: ferrer lopez p. Biochem Pharmacol. 1989 May 1;38(9):1373-84. doi: 10.1016/0006-2952(89)90175-5. Biochem Pharmacol. 1989. PMID: 2655601 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page